Advertisement

Garth Strohbehn, MD, MPhil, on Applied Clinical Pharmacology in a Crisis: Interventional Pharmacoeconomics and COVID-19

First International Summit on Interventional Pharmacoeconomics

Advertisement

Related Videos

Kelvin Chan, MD, FRCPC, MSc, PhD, on Opportunities to Optimize Cancer Drug Policies: The Canadian Perspective

Welcome and Introduction to Vi3C

Boon-Cher Goh, MD, on Cancer Drugs in Singapore: 3As (Availability, Accessibility, and Affordability)

Victoria T. Brown, PharmD, BCOP, on Payer Intervention: The Example of Abiraterone

Blase Polite, MD, MPP, FASCO, on Transforming the Drug Cost Curve in the United States: Not How But If

Advertisement

Advertisement

Mar

19

Today In Oncology

AMA Survey Finds Rapid Growth in Physician AI Adoption

For Most Men With Prostate Cancer, Hormone Therapy With Postprostatectomy Radiotherapy Confers No Survival Benefit

High Cancer Burden Shifted From Urban to Rural Areas

Study Finds No Overall Increase in Cancer Risk After Medically Assisted Reproduction

SMFM Issues New Clinical Guidance for Cancer Diagnosis and Treatment During Pregnancy

Advertisement

© 2026 HSP News Service, L.L.C.